Symbol="ZYNE"
AssetType="Common Stock"
Name="Zynerba Pharmaceuticals Inc"
Description="Zynerba Pharmaceuticals, Inc. is a specialty clinical-stage pharmaceutical company. The company is headquartered in Devon, Pennsylvania."
CIK="1621443"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="68675000"
EBITDA="-36608576"
PERatio="None"
PEGRatio="0"
BookValue="1.01"
DividendPerShare="0"
DividendYield="0"
EPS="-0.81"
RevenuePerShareTTM="0.004"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.374"
ReturnOnEquityTTM="-0.704"
RevenueTTM="86000"
GrossProfitTTM="0"
DilutedEPSTTM="-0.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="1.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1152.69"
PriceToBookRatio="0.536"
EVToRevenue="397.61"
EVToEBITDA="0.776"
Beta="1.762"
num_52WeekHigh="1.38"
num_52WeekLow="0.25"
num_50DayMovingAverage="0.423"
num_200DayMovingAverage="0.481"
SharesOutstanding="53652000"
DividendDate="None"
ExDividendDate="None"
symbol="ZYNE"
open="1.29"
high="1.32"
low="1.26"
price="1.32"
volume="1163999.00"
latest_trading_day="2023-08-18"
previous_close="1.28"
change="0.04"
change_percent="3.1250%"
aroon_positive_momentum_days="15"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="491591"
Change_recent_avg="0.01"
Delta_recent_avg="0.03"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-1.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="1105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="588"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="981"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0143.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
